Hypertension Clinical Trials in Chicago

Showing 221-240 of 252 trials

Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension

NCT00853957

The purpose of the study is to evaluate the BP-lowering efficacy of the combination of aliskiren and amlodipine, as initial therapy, compared to amlodipine monotherapy in African American patients with Stage II hypertension.

Hypertension

Novartis443 participantsStarted Feb 2009

Chicago, Illinois, United States • Baltimore, Maryland, United States • Oxon Hill, Maryland, United States +6 more locations

COMPLETEDPhase 22.2 miles

A Trial to Evaluate the Safety and Efficacy of PS433540 to Treat Hypertension

NCT00522925

The purpose of the study is to see if PS433540 lowers blood pressure better than placebo and to see how safe PS433540 is compared to placebo.

Hypertension

Ligand Pharmaceuticals280 participantsStarted Aug 2007

Tempe, Arizona, United States • Lincoln, California, United States • Long Beach, California, United States +12 more locations

Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension

A Trial to Evaluate the Safety and Efficacy of PS433540 to Treat Hypertension

Hypertension Trials in Other Cities

Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients

An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.

The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease

ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)

Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis

Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe Hypertension

Clinical Trial to Assess the Effects of Low-fat Dairy on Systolic Blood Pressure

Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension

Secondary Prevention of Small Subcortical Strokes Trial

Effect of High and Low Sodium Diets on Blood Pressure in Hypertensive Patients Treated With Aliskiren

18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics

Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)

Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients

One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response of Vasomera (PB1046) Injection Following a Single Subcutaneous Dose in Subjects With Stage 1 or 2 Essential Hypertension

A Study Of Different Doses Of TBC3711 In Patients With Uncontrolled High Blood Pressure Already Taking Medications For High Blood Pressure.

Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension

Efficacy and Safety of the Combination Aliskiren (300 mg) and Hydrochlorothiazide (25mg) to Aliskiren (300mg) Monotherapy in Patients With Staged II Hypertension

Other Conditions in Chicago